FDA Reverses Stance on Leucovorin for Autism

(MedPage Today) — The FDA expanded the approval of leucovorin calcium (Wellcovorin) tablets to treat FOLR1-related cerebral folate transport deficiency (CFD-FOLR1), an ultra-rare hereditary disorder, the agency announced Tuesday.
Leucovorin is…

Source link : https://www.medpagetoday.com/neurology/autism/120245

Author :

Publish date : 2026-03-10 21:00:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30

FDA Reverses Stance on Leucovorin for Autism

Some Cancers May Be Slightly Elevated in Women Who’ve Had Fertility Treatment

Senator to Investigate FDA Rejections of Rare Disease Drugs

Related Posts

Two Resuscitation Fluids Led to Similar Outcomes in Kids With Septic Shock

AOC vs RFK Jr. Memes; Are Doctors OK? Communicating With Gen Z Patients

‘Ozempic Personality’: Is Emotional Flattening Another Side Effect of GLP-1s?

Omalizumab Plus Immunotherapy May Ease Allergic Asthma

First Gene Therapy Approved for Hearing Loss

Think Heart Attacks Cause Most Sudden Cardiac Deaths? Think Again, Study Says

Two Resuscitation Fluids Led to Similar Outcomes in Kids With Septic Shock

AOC vs RFK Jr. Memes; Are Doctors OK? Communicating With Gen Z Patients

‘Ozempic Personality’: Is Emotional Flattening Another Side Effect of GLP-1s?

Omalizumab Plus Immunotherapy May Ease Allergic Asthma

First Gene Therapy Approved for Hearing Loss

Think Heart Attacks Cause Most Sudden Cardiac Deaths? Think Again, Study Says

FDA, CMS to Launch Speedy Coverage Pathway for Breakthrough Medical Devices

DMR Slows Post-Tirzepatide Weight Regain

Categories

Archives